drugset / Trial / NCT03936556

A Clinical Study to Assess the Effects of a Stannous Fluoride Dentifrice on Plaque and Gingivitis

NCT03936556

Phase 4 Completed 84 enrolled Procter and Gamble
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this clinical study is to assess the effects of a 0.454% stannous fluoride dentifrice on gingivitis and plaque after 3 months when compared to a negative control.

Timeline

Start
2018-02-25
Primary completion
2018-06-03
Completion
2018-06-03

Drugs

EvaluationDrugModalityDoseRoute
Subject stannous fluoride Small molecule 0.454 %

Indications